Nutrien Ltd.(NTR)Earnings, Financials & Key Ratios
NTR•NYSE
$73.81
$35.51B mkt cap·15.6× P/E·Price updated May 6, 2026
AboutNutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia. In addition, it provides services directly to growers through a network of farm centers in North America, South America, and Australia. The company was founded in 2017 and is headquartered in Saskatoon, Canada.Show more
- Revenue$27.36B+5.3%
- EBITDA$6.37B+20.4%
- Net Income$2.31B+242.2%
- EPS (Diluted)4.74+248.5%
- Gross Margin31.05%+7.1%
- EBITDA Margin23.29%+14.3%
- Operating Margin14.48%+27.4%
- Net Margin8.43%+224.9%
- ROE9.27%+241.4%
- ROIC8.03%+32.9%
- Debt/Equity0.51-2.5%
- Interest Coverage5.44+91.8%
NTR Key Insights
Nutrien Ltd. (NTR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 38.1%
- ✓Strong Piotroski F-Score: 8/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy dividend yield of 3.0%
- ✓Trading at only 1.4x book value
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
NTR Price & Volume
Nutrien Ltd. (NTR) stock price & volume — 10-year historical chart
Loading chart...
NTR Growth Metrics
Nutrien Ltd. (NTR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years15.86%
5 Years5.52%
3 Years-10.29%
TTM3.57%
Profit CAGR
10 Years6.15%
5 Years38.11%
3 Years-32.97%
TTM236.89%
EPS CAGR
10 Years2.23%
5 Years41.02%
3 Years-29.66%
TTM241.22%
Return on Capital
10 Years8.02%
5 Years13.4%
3 Years8.89%
Last Year9.78%
NTR Recent Earnings
Nutrien Ltd. (NTR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 5/12 qtrs (42%)
Q1 2026Latest
Feb 18, 2026EPS
$0.83
Est $0.87
-4.6%
Revenue
$5.1B
Est $5.4B
-5.6%
Q4 2025
Nov 5, 2025EPS
$0.97
Est $0.93
+4.3%
Revenue
$5.9B
Est $5.2B
+13.2%
Q3 2025
Aug 6, 2025EPS
$2.65
Est $2.40
+10.4%
Revenue
$10.4B
Est $10.4B
-0.1%
Q2 2025
May 7, 2025EPS
$0.11
Est $0.33
-66.7%
Revenue
$5.1B
Est $5.1B
-0.9%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 18, 2026 | $0.83vs $0.87-4.6% | $5.1Bvs $5.4B-5.6% |
| Q4 2025 | Nov 5, 2025 | $0.97vs $0.93+4.3% | $5.9Bvs $5.2B+13.2% |
| Q3 2025 | Aug 6, 2025 | $2.65vs $2.40+10.4% | $10.4Bvs $10.4B-0.1% |
| Q2 2025 | May 7, 2025 | $0.11vs $0.33-66.7% | $5.1Bvs $5.1B-0.9% |
Based on last 12 quarters of dataView full earnings history →
NTR Peer Comparison
Nutrien Ltd. (NTR) competitors in Ag input retail and farm services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MOS | 7.48B | 23.56 | 6.07 | 5.03% | 10.46% | 9.99% | 0.06 | |
 CF | 18.39B | 119.74 | 13.35 | 19.34% | 23.73% | 20.41% | 0.51 | |
 ICL | 7.25B | 5.62 | 31.22 | 4.56% | 5.23% | 5.78% | 0.44 | |
 SMG | 3.65B | 62.85 | 25.45 | -3.93% | 2.68% | |||
 AVD | 83.05M | 2.91 | -1.66 | -5.88% | -8.71% | -21.86% | 0.99 | |
 FMC | 1.85B | 14.79 | -0.83 | -18.34% | -72.93% | -82.27% | 2.00 | |
 CTVA | 54.89B | 81.76 | 51.10 | 2.92% | 6.5% | 4.62% | 0.11 | |
 UAN | 1.38B | 130.40 | 13.98 | 15.36% | 18.89% | 40.08% | 2.23 |
Compare NTR vs Peers
Nutrien Ltd. (NTR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NTR Income Statement
Nutrien Ltd. (NTR) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 4.55B | 19.64B | 20.08B | 20.91B | 27.71B | 37.88B | 29.06B | 25.97B | 27.36B |
| Revenue Growth % | 2.04% | 331.85% | 2.28% | 4.1% | 32.54% | 36.71% | -23.3% | -10.61% | 5.33% |
| Cost of Goods Sold | 3.85B | 14.24B | 14.58B | 15.67B | 18.3B | 22.46B | 20.58B | 18.44B | 18.86B |
| COGS % of Revenue | 84.74% | 72.54% | 72.61% | 74.94% | 66.05% | 59.29% | 70.84% | 71.01% | 68.95% |
| Gross Profit | 694M▲ 0% | 5.39B▲ 676.9% | 5.5B▲ 2.0% | 5.24B▼ 4.8% | 9.41B▲ 79.6% | 15.42B▲ 63.9% | 8.47B▼ 45.1% | 7.53B▼ 11.1% | 8.49B▲ 12.8% |
| Gross Margin % | 15.26% | 27.46% | 27.39% | 25.06% | 33.95% | 40.71% | 29.16% | 28.99% | 31.05% |
| Gross Profit Growth % | -16.39% | 676.95% | 2.04% | -4.78% | 79.6% | 63.93% | -45.06% | -11.14% | 12.79% |
| Operating Expenses | 485M | 4.98B | 3.64B | 4.34B | 4.63B | 4.62B | 4.61B | 4.58B | 4.53B |
| OpEx % of Revenue | 10.67% | 25.35% | 18.12% | 20.74% | 16.7% | 12.18% | 15.88% | 17.63% | 16.57% |
| Selling, General & Admin | 214M | 2.88B | 3.01B | 3.31B | 3.82B | 4.09B | 4.06B | 4.17B | 4.15B |
| SG&A % of Revenue | 4.71% | 14.65% | 15% | 15.84% | 13.79% | 10.8% | 13.99% | 16.07% | 15.19% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 271M | 2.1B | 627M | 1.03B | 807M | 523M | 550M | 406M | 378.51M |
| Operating Income | 209M▲ 0% | 414M▲ 98.1% | 1.86B▲ 349.8% | 902M▼ 51.6% | 4.78B▲ 430.0% | 10.81B▲ 126.1% | 3.86B▼ 64.3% | 2.95B▼ 23.5% | 3.96B▲ 34.2% |
| Operating Margin % | 4.6% | 2.11% | 9.27% | 4.31% | 17.25% | 28.53% | 13.28% | 11.36% | 14.48% |
| Operating Income Growth % | -54.47% | 98.09% | 349.76% | -51.56% | 430.04% | 126.08% | -64.29% | -23.55% | 34.2% |
| EBITDA | 901M | 2.01B | 3.66B | 2.89B | 6.73B | 12.82B | 6.03B | 5.29B | 6.37B |
| EBITDA Margin % | 19.82% | 10.22% | 18.23% | 13.83% | 24.29% | 33.84% | 20.75% | 20.37% | 23.29% |
| EBITDA Growth % | -21.92% | 122.64% | 82.5% | -21.03% | 132.86% | 90.45% | -52.98% | -12.26% | 20.43% |
| D&A (Non-Cash Add-back) | 692M | 1.59B | 1.8B | 1.99B | 1.95B | 2.01B | 2.17B | 2.34B | 2.41B |
| EBIT | 211M | 431M | 1.87B | 903M | 4.63B | 10.77B | 2.72B | 1.87B | 3.8B |
| Net Interest Income | -238M | -538M | -554M | -520M | -466.86M | -505.16M | -768.85M | -634.02M | -699.03M |
| Interest Income | 2M | 17M | 5M | 1M | 7.93M | 24.01M | 35.64M | 26.66M | 0 |
| Interest Expense | 240M | 555M | 559M | 521M | 474.79M | 529.17M | 804.49M | 660.68M | 699.03M |
| Other Income/Expense | -238M | -538M | -554M | -520M | -613M | -563M | -1.91B | -1.81B | -857.76M |
| Pretax Income | -29M▲ 0% | -124M▼ 327.6% | 1.31B▲ 1154.8% | 382M▼ 70.8% | 4.17B▲ 991.1% | 10.25B▲ 145.8% | 1.95B▼ 80.9% | 1.14B▼ 41.8% | 3.1B▲ 173.1% |
| Pretax Margin % | -0.64% | -0.63% | 6.51% | 1.83% | 15.04% | 27.05% | 6.72% | 4.37% | 11.34% |
| Income Tax | -183M | -93M | 316M | -77M | 989M | 2.56B | 670M | 436M | 765.16M |
| Effective Tax Rate % | 631.03% | 75% | 24.16% | -20.16% | 23.73% | 24.98% | 34.32% | 38.38% | 24.66% |
| Net Income | 327M▲ 0% | 3.57B▲ 992.7% | 992M▼ 72.2% | 459M▼ 53.7% | 3.15B▲ 586.9% | 7.66B▲ 142.9% | 1.26B▼ 83.6% | 674M▼ 46.4% | 2.31B▲ 242.2% |
| Net Margin % | 7.19% | 18.2% | 4.94% | 2.2% | 11.38% | 20.22% | 4.33% | 2.6% | 8.43% |
| Net Income Growth % | -2.68% | 992.66% | -72.24% | -53.73% | 586.93% | 142.94% | -83.58% | -46.42% | 242.24% |
| Net Income (Continuing) | 154M | -31M | 992M | 459M | 3.18B | 7.69B | 1.28B | 700M | 2.34B |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 38M | 47M | 45M | 45M | 35M | 41.92M |
| EPS (Diluted) | 0.98▲ 0% | 5.72▲ 483.7% | 1.74▼ 69.6% | 0.85▼ 51.1% | 5.47▲ 543.5% | 13.62▲ 149.0% | 2.53▼ 81.4% | 1.36▼ 46.2% | 4.74▲ 248.5% |
| EPS Growth % | -2% | 483.67% | -69.58% | -51.15% | 543.53% | 148.99% | -81.42% | -46.25% | 248.53% |
| EPS (Basic) | 0.98 | 5.76 | 1.74 | 0.85 | 5.49 | 13.66 | 2.53 | 1.36 | 4.74 |
| Diluted Shares Outstanding | 336.13M | 624.9M | 583.1M | 569.69M | 571.29M | 540.01M | 496.99M | 494.37M | 486.52M |
| Basic Shares Outstanding | 336.03M | 620M | 582.27M | 569.66M | 569.66M | 538.48M | 496.38M | 494.37M | 486.33M |
| Dividend Payout Ratio | 100.92% | 26.64% | 103.02% | 224.4% | 33.14% | 13.46% | 82.03% | 157.27% | 46.8% |
NTR Balance Sheet
Nutrien Ltd. (NTR) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 3.32B | 11.66B | 10.66B | 11.47B | 13.85B | 16.34B | 14.17B | 13.79B | 14.72B |
| Cash & Short-Term Investments | 116M | 2.31B | 671M | 1.45B | 499M | 901M | 941M | 853M | 699.72M |
| Cash Only | 116M | 2.31B | 671M | 1.45B | 499M | 901M | 941M | 853M | 699.72M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 390M | 2.75B | 3.05B | 3.02B | 4.71B | 5.6B | 4.67B | 5.39B | 5.66B |
| Days Sales Outstanding | 31.31 | 51.04 | 55.38 | 52.7 | 61.97 | 53.92 | 58.64 | 75.75 | 75.58 |
| Inventory | 788M | 4.92B | 4.97B | 4.93B | 6.33B | 7.63B | 6.34B | 6.15B | 6.96B |
| Days Inventory Outstanding | 74.65 | 126 | 124.53 | 114.84 | 126.19 | 124.03 | 112.36 | 121.68 | 134.76 |
| Other Current Assets | 1.96B | 596M | 495M | 607M | 661M | 598M | 730M | 0 | 1.39B |
| Total Non-Current Assets | 13.68B | 33.84B | 36.13B | 35.72B | 36.11B | 38.24B | 38.58B | 38.05B | 37.48B |
| Property, Plant & Equipment | 12.97B | 18.8B | 20.34B | 19.66B | 20.02B | 21.77B | 22.46B | 22.6B | 22.71B |
| Fixed Asset Turnover | 0.35x | 1.04x | 0.99x | 1.06x | 1.38x | 1.74x | 1.29x | 1.15x | 1.20x |
| Goodwill | 97M | 11.43B | 11.99B | 12.2B | 12.22B | 12.37B | 12.11B | 12.04B | 12.11B |
| Intangible Assets | 69M | 2.21B | 2.43B | 2.39B | 2.34B | 2.3B | 2.22B | 1.82B | 1.66B |
| Long-Term Investments | 292M | 878M | 821M | 562M | 703M | 843M | 736M | 698M | 143.74M |
| Other Non-Current Assets | 228M | 309M | 315M | 672M | 567M | 521M | 574M | 483M | 856.44M |
| Total Assets | 17B▲ 0% | 45.5B▲ 167.7% | 46.8B▲ 2.9% | 47.19B▲ 0.8% | 49.95B▲ 5.9% | 54.59B▲ 9.3% | 52.75B▼ 3.4% | 51.84B▼ 1.7% | 52.21B▲ 0.7% |
| Asset Turnover | 0.27x | 0.43x | 0.43x | 0.44x | 0.55x | 0.69x | 0.55x | 0.50x | 0.52x |
| Asset Growth % | -1.6% | 167.69% | 2.85% | 0.84% | 5.85% | 9.27% | -3.37% | -1.72% | 0.71% |
| Total Current Liabilities | 1.6B | 8.34B | 9.13B | 8.48B | 12.44B | 14.28B | 12.12B | 12.04B | 11.02B |
| Accounts Payable | 255M | 3.05B | 4.02B | 4.42B | 5.18B | 5.8B | 5.48B | 5.36B | 9.29B |
| Days Payables Outstanding | 24.16 | 78.23 | 100.52 | 102.84 | 103.28 | 94.21 | 97.13 | 106.06 | 179.81 |
| Short-Term Debt | 730M | 1.62B | 1.48B | 173M | 2.1B | 2.68B | 2.33B | 2.57B | 1.73B |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 438M | 3.02B | 2.15B | 2.31B | 3.14B | 3.71B | 2.6B | 2.47B | 0 |
| Current Ratio | 2.07x | 1.40x | 1.17x | 1.35x | 1.11x | 1.14x | 1.17x | 1.15x | 1.34x |
| Quick Ratio | 1.58x | 0.81x | 0.62x | 0.77x | 0.60x | 0.61x | 0.65x | 0.63x | 0.70x |
| Cash Conversion Cycle | 81.8 | 98.81 | 79.38 | 64.7 | 84.88 | 83.74 | 73.87 | 91.36 | 30.54 |
| Total Non-Current Liabilities | 7.09B | 12.74B | 14.8B | 16.31B | 13.81B | 14.44B | 15.43B | 15.35B | 15.87B |
| Long-Term Debt | 3.71B | 7.58B | 8.55B | 10.05B | 7.52B | 8.04B | 8.91B | 8.88B | 10.27B |
| Capital Lease Obligations | 0 | 12M | 859M | 891M | 934M | 899M | 999M | 999M | 935.29M |
| Deferred Tax Liabilities | 2.21B | 2.91B | 3.15B | 3.15B | 3.17B | 3.55B | 3.57B | 3.54B | 3.66B |
| Other Non-Current Liabilities | 1.18B | 2.24B | 2.24B | 2.22B | 2.19B | 1.96B | 1.94B | 1.93B | 1B |
| Total Liabilities | 8.7B | 21.08B | 23.93B | 24.79B | 26.25B | 28.72B | 27.55B | 27.4B | 26.89B |
| Total Debt | 4.44B | 9.22B | 11.1B | 11.36B | 10.85B | 11.93B | 12.57B | 12.81B | 12.93B |
| Net Debt | 4.33B | 6.91B | 10.43B | 9.91B | 10.35B | 11.03B | 11.63B | 11.95B | 12.23B |
| Debt / Equity | 0.53x | 0.38x | 0.49x | 0.51x | 0.46x | 0.46x | 0.50x | 0.52x | 0.51x |
| Debt / EBITDA | 4.93x | 4.60x | 3.03x | 3.93x | 1.61x | 0.93x | 2.08x | 2.42x | 2.03x |
| Net Debt / EBITDA | 4.80x | 3.44x | 2.85x | 3.43x | 1.54x | 0.86x | 1.93x | 2.26x | 1.92x |
| Interest Coverage | 0.88x | 0.78x | 3.34x | 1.73x | 9.75x | 20.35x | 3.38x | 2.83x | 5.44x |
| Total Equity | 8.3B▲ 0% | 24.43B▲ 194.2% | 22.87B▼ 6.4% | 22.4B▼ 2.0% | 23.7B▲ 5.8% | 25.86B▲ 9.1% | 25.2B▼ 2.6% | 24.44B▼ 3.0% | 25.32B▲ 3.6% |
| Equity Growth % | 1.11% | 194.17% | -6.37% | -2.04% | 5.78% | 9.13% | -2.56% | -3.01% | 3.59% |
| Book Value per Share | 24.70 | 39.09 | 39.22 | 39.33 | 41.48 | 47.89 | 50.71 | 49.44 | 52.04 |
| Total Shareholders' Equity | 8.3B | 24.43B | 22.87B | 22.36B | 23.65B | 25.82B | 25.16B | 24.41B | 25.28B |
| Common Stock | 1.81B | 16.74B | 15.77B | 15.67B | 15.46B | 14.17B | 13.84B | 13.75B | 13.49B |
| Retained Earnings | 6.24B | 7.75B | 7.1B | 6.61B | 8.19B | 11.93B | 11.53B | 11.11B | 12.05B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 25M | -291M | -251M | -119M | -146M | -391M | -296M | -515M | -328.4M |
| Minority Interest | 0 | 0 | 0 | 38M | 47M | 45M | 45M | 35M | 41.92M |
NTR Cash Flow Statement
Nutrien Ltd. (NTR) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.23B | 2.05B | 3.67B | 3.32B | 3.89B | 8.11B | 5.07B | 3.54B | 4.08B |
| Operating CF Margin % | 26.94% | 10.45% | 18.25% | 15.89% | 14.02% | 21.41% | 17.44% | 13.61% | 14.9% |
| Operating CF Growth % | -2.78% | 67.51% | 78.61% | -9.33% | 16.94% | 108.7% | -37.53% | -30.22% | 15.34% |
| Net Income | 327M | -826M | 992M | 459M | 3.18B | 7.69B | 1.28B | 700M | 2.31B |
| Depreciation & Amortization | 692M | 1.59B | 1.8B | 1.99B | 1.95B | 2.01B | 2.17B | 2.34B | 2.41B |
| Stock-Based Compensation | 11M | 116M | 104M | 69M | 198M | 63M | -14M | 37M | 0 |
| Deferred Taxes | -273M | 687M | 177M | -9M | -31M | 455M | -58M | 78M | 254.38M |
| Other Non-Cash Items | 396M | 1.62B | 103M | 241M | 250M | -959M | 1.18B | 868M | -97.68M |
| Working Capital Changes | 72M | -1.14B | 490M | 574M | -1.66B | -1.15B | 507M | -487M | -796.71M |
| Change in Receivables | 47M | -153M | -64M | 145M | -1.67B | -919M | 879M | -224M | -130.24M |
| Change in Inventory | -10M | -887M | 190M | 85M | -1.46B | -1.28B | 1.38B | 60M | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -99.72M |
| Cash from Investing | -652M | 3.89B | -2.8B | -1.2B | -1.81B | -2.9B | -2.96B | -2.13B | -1.4B |
| Capital Expenditures | -651M | -1.41B | -1.73B | -1.42B | -1.88B | -2.48B | -2.6B | -2.15B | -2.04B |
| CapEx % of Revenue | 14.32% | 7.16% | 8.6% | 6.81% | 6.8% | 6.53% | 8.95% | 8.29% | 7.46% |
| Acquisitions | 0 | 33M | -911M | -233M | -88M | -407M | -153M | -21M | -23.4M |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -1M | 5.39B | 39M | 14M | 165M | -19M | -62M | 110M | -55.96M |
| Cash from Financing | -489M | -3.71B | -2.48B | -1.34B | -3B | -4.73B | -2.06B | -1.45B | -2.87B |
| Debt Issued (Net) | -159M | -939M | 482M | -134M | -1.1B | 672M | 19M | -181M | -800.78M |
| Equity Issued (Net) | 1M | -1.79B | -1.91B | -160M | -835M | -4.35B | -1.01B | -166M | -521.98M |
| Dividends Paid | -330M | -952M | -1.02B | -1.03B | -1.04B | -1.03B | -1.03B | -1.06B | -1.08B |
| Share Repurchases | 0 | -1.8B | -1.93B | -160M | -1.03B | -4.52B | -1.05B | -184M | -560.65M |
| Other Financing | -1M | -21M | -29M | -15M | -21M | -20M | -34M | -46M | -463.98M |
| Net Change in Cash | 84M▲ 0% | 2.2B▲ 2516.7% | -1.64B▼ 174.7% | 783M▲ 147.7% | -955M▼ 222.0% | 402M▲ 142.1% | 40M▼ 90.0% | -88M▼ 320.0% | -152.77M▼ 73.6% |
| Free Cash Flow | 574M▲ 0% | 545M▼ 5.1% | 1.77B▲ 225.5% | 1.77B▲ 0.0% | 2B▲ 12.9% | 5.63B▲ 181.5% | 2.47B▼ 56.2% | 1.38B▼ 44.0% | 2.04B▲ 47.5% |
| FCF Margin % | 12.62% | 2.78% | 8.83% | 8.48% | 7.22% | 14.87% | 8.49% | 5.32% | 7.45% |
| FCF Growth % | 56.4% | -5.05% | 225.5% | 0% | 12.85% | 181.47% | -56.24% | -44% | 47.51% |
| FCF per Share | 1.71 | 0.87 | 3.04 | 3.11 | 3.50 | 10.43 | 4.96 | 2.79 | 4.19 |
| FCF Conversion (FCF/Net Income) | 3.75x | 0.57x | 3.69x | 7.24x | 1.23x | 1.06x | 4.03x | 5.24x | 1.77x |
| Interest Paid | 198M | 507M | 505M | 498M | 491M | 482M | 729M | 740M | 0 |
| Taxes Paid | 83M | 1.16B | 29M | 156M | 435M | 1.88B | 1.76B | 321M | 0 |
NTR Key Ratios
Nutrien Ltd. (NTR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 4.05% | 3.96% | 21.83% | 4.2% | 2.03% | 13.68% | 30.91% | 4.93% | 2.72% | 9.27% |
| Return on Invested Capital (ROIC) | 2.72% | 1.23% | 1.41% | 4.32% | 2.06% | 10.81% | 22.86% | 7.85% | 6.05% | 8.03% |
| Gross Margin | 18.63% | 15.26% | 27.46% | 27.39% | 25.06% | 33.95% | 40.71% | 29.16% | 28.99% | 31.05% |
| Net Margin | 7.54% | 7.19% | 18.2% | 4.94% | 2.2% | 11.38% | 20.22% | 4.33% | 2.6% | 8.43% |
| Debt / Equity | 0.56x | 0.53x | 0.38x | 0.49x | 0.51x | 0.46x | 0.46x | 0.50x | 0.52x | 0.51x |
| Interest Coverage | 2.11x | 0.88x | 0.78x | 3.34x | 1.73x | 9.75x | 20.35x | 3.38x | 2.83x | 5.44x |
| FCF Conversion | 3.75x | 3.75x | 0.57x | 3.69x | 7.24x | 1.23x | 1.06x | 4.03x | 5.24x | 1.77x |
| Revenue Growth | -29.03% | 2.04% | 331.85% | 2.28% | 4.1% | 32.54% | 36.71% | -23.3% | -10.61% | 5.33% |
NTR Frequently Asked Questions
Nutrien Ltd. (NTR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Nutrien Ltd. (NTR) reported $26.90B in revenue for fiscal year 2025. This represents a 1816% increase from $1.40B in 1996.
Nutrien Ltd. (NTR) grew revenue by 5.3% over the past year. This is steady growth.
Yes, Nutrien Ltd. (NTR) is profitable, generating $2.27B in net income for fiscal year 2025 (8.4% net margin).
Dividend & Returns
Yes, Nutrien Ltd. (NTR) pays a dividend with a yield of 3.01%. This makes it attractive for income-focused investors.
Nutrien Ltd. (NTR) has a return on equity (ROE) of 9.3%. This is below average, suggesting room for improvement.
Nutrien Ltd. (NTR) generated $1.98B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More NTR
Nutrien Ltd. (NTR) financial analysis — history, returns, DCA and operating performance tools
Full NTR Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates